» Articles » PMID: 11830511

Possible Oncogenic Potential of DeltaNp73: a Newly Identified Isoform of Human P73

Overview
Journal Cancer Res
Specialty Oncology
Date 2002 Feb 7
PMID 11830511
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

p73, a recently identified gene highly homologous to p53, can transactivate p53 target genes and induce apoptosis. Here we report the identification of an NH(2)-terminal truncated isoform of human p73, DeltaNp73, which is capable of suppressing p53- and p73-dependent transactivation. We speculate that this suppression is achieved by competing for the DNA binding site in the case of p53 and by direct association in the case of TAp73. Expression of DeltaNp73 in cancer cell lines also inhibited suppressive activity of p53 and TAp73 in colony formation, implying possible involvement of DeltaNp73 in oncogenesis by inhibiting the tumor-suppressive function of p53 and TAp73. Also reported is the identification of TAp73eta, a new member of the COOH-terminal truncated isoform of p73 and tissue-specific expression of these isoforms, along with other previously identified p73 isoforms.

Citing Articles

TAp73 and ΔTAp73 isoforms show cell-type specific distributions and alterations in cancer.

Hrabal V, Stenckova M, Zavadil Kokas F, Muller P, Nenutil R, Vojtesek B Sci Rep. 2024; 14(1):29949.

PMID: 39622910 PMC: 11612387. DOI: 10.1038/s41598-024-80927-9.


Re-appraising the evidence for the source, regulation and function of p53-family isoforms.

Lopez I, Valdivia I, Vojtesek B, Fahraeus R, Coates P Nucleic Acids Res. 2024; 52(20):12112-12129.

PMID: 39404067 PMC: 11551734. DOI: 10.1093/nar/gkae855.


DNp73 enhances tumor progression and immune evasion in multiple myeloma by targeting the MYC and MYCN pathways.

Liu L, Gong D, Sun H, Feng F, Xu J, Sun X Front Immunol. 2024; 15:1470328.

PMID: 39380995 PMC: 11459316. DOI: 10.3389/fimmu.2024.1470328.


Prognostic implications of ΔNp73/TAp73 expression ratio in core-binding factor acute myeloid leukemia.

Salustiano-Bandeira M, Moreira-Aguiar A, Pereira-Martins D, Coelho-Silva J, Weinhauser I, Franca-Neto P Blood Cancer J. 2024; 14(1):102.

PMID: 38914584 PMC: 11196665. DOI: 10.1038/s41408-024-01086-8.


The RUNX Family Defines Trk Phenotype and Aggressiveness of Human Neuroblastoma through Regulation of p53 and MYCN.

Ando K, Nakagawara A Cells. 2023; 12(4).

PMID: 36831211 PMC: 9954111. DOI: 10.3390/cells12040544.